Abstract

Haematopoietic stem cells (HSCs) are characterized by their self-renewal potential associated to dormancy. Here we identify the cell surface receptor neogenin-1 as specifically expressed in dormant HSCs. Loss of neogenin-1 initially leads to increased HSC expansion but subsequently to loss of self-renewal and premature exhaustion in vivo. Its ligand netrin-1 induces Egr1 expression and maintains quiescence and function of cultured HSCs in a Neo1 dependent manner. Produced by arteriolar endothelial and periarteriolar stromal cells, conditional netrin-1 deletion in the bone marrow niche reduces HSC numbers, quiescence and self-renewal, while overexpression increases quiescence in vivo. Ageing associated bone marrow remodelling leads to the decline of netrin-1 expression in niches and a compensatory but reversible upregulation of neogenin-1 on HSCs. Our study suggests that niche produced netrin-1 preserves HSC quiescence and self-renewal via neogenin-1 function. Decline of netrin-1 production during ageing leads to the gradual decrease of Neo1 mediated HSC self-renewal.

Haematopoietic stem cells (HSCs) are characterized by their self-renewal potential and associated dormancy. Here the authors show that niche produced netrin-1 preserves HSC quiescence and self-renewal via neogenin-1, and that decline of netrin-1 production during ageing leads to decreased Neo1 mediated HSC self-renewal.

Details

Title
Niche derived netrin-1 regulates hematopoietic stem cell dormancy via its receptor neogenin-1
Author
Renders, Simon 1 ; Svendsen, Arthur Flohr 2 ; Panten Jasper 3 ; Rama, Nicolas 4   VIAFID ORCID Logo  ; Maryanovich, Maria 5   VIAFID ORCID Logo  ; Sommerkamp Pia 3 ; Ladel Luisa 6 ; Redavid, Anna Rita 4 ; Gibert, Benjamin 4   VIAFID ORCID Logo  ; Lazare Seka 7 ; Ducarouge Benjamin 4 ; Schönberger Katharina 8 ; Narr, Andreas 3 ; Tourbez Manon 9 ; Dethmers-Ausema Bertien 9 ; Zwart, Erik 9   VIAFID ORCID Logo  ; Hotz-Wagenblatt Agnes 10 ; Zhang Dachuan 5   VIAFID ORCID Logo  ; Korn, Claudia 11 ; Zeisberger Petra 6 ; Przybylla Adriana 6 ; Sohn, Markus 6 ; Mendez-Ferrer, Simon 11   VIAFID ORCID Logo  ; Heikenwälder Mathias 12   VIAFID ORCID Logo  ; Brune Maik 13 ; Klimmeck, Daniel 6 ; Bystrykh Leonid 14   VIAFID ORCID Logo  ; Frenette, Paul S 5   VIAFID ORCID Logo  ; Mehlen Patrick 4 ; de Haan Gerald 7   VIAFID ORCID Logo  ; Cabezas-Wallscheid Nina 8   VIAFID ORCID Logo  ; Trumpp, Andreas 15   VIAFID ORCID Logo 

 German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Division of Stem Cells and Cancer, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany (GRID:grid.482664.a); Heidelberg University Hospital, Department of Internal Medicine V, Heidelberg, Germany (GRID:grid.5253.1) (ISNI:0000 0001 0328 4908) 
 University Medical Center Groningen, University of Groningen, Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, Groningen, The Netherlands (GRID:grid.5253.1) 
 German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Division of Stem Cells and Cancer, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany (GRID:grid.482664.a); Heidelberg University, Faculty of Biosciences, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373) 
 Centre Léon Bérard, Apoptosis, Cancer and Development Laboratory, Equipe labellisée “La Ligue,” LabEx DEVweCAN, Institut Convergence Rabelais, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon1, Lyon, France (GRID:grid.418116.b) (ISNI:0000 0001 0200 3174) 
 Albert Einstein College of Medicine, Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Bronx, USA (GRID:grid.251993.5) (ISNI:0000000121791997); Albert Einstein College of Medicine, Department of Cell Biology, Bronx, USA (GRID:grid.251993.5) (ISNI:0000000121791997); Albert Einstein College of Medicine, Department of Medicine, Bronx, USA (GRID:grid.251993.5) (ISNI:0000000121791997) 
 German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Division of Stem Cells and Cancer, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany (GRID:grid.482664.a) 
 University Medical Center Groningen, University of Groningen, Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, Groningen, The Netherlands (GRID:grid.418116.b) 
 Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany (GRID:grid.429509.3) (ISNI:0000 0004 0491 4256) 
 University Medical Center Groningen, University of Groningen, Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, Groningen, The Netherlands (GRID:grid.7700.0) 
10  German Cancer Research Center (DKFZ), Core Facility Omics IT and Data Management, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584) 
11  University of Cambridge, Wellcome Trust/MRC Cambridge Stem Cell Institute, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge, Department of Haematology, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); NHS Blood and Transplant, Cambridge, UK (GRID:grid.436365.1) (ISNI:0000 0000 8685 6563) 
12  German Cancer Research Center Heidelberg (DKFZ), Division of Chronic Inflammation and Cancer, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584) 
13  Heidelberg University Hospital, Department of Internal Medicine I and Clinical Chemistry, Heidelberg, Germany (GRID:grid.5253.1) (ISNI:0000 0001 0328 4908) 
14  University Medical Center Groningen, University of Groningen, Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, Groningen, The Netherlands (GRID:grid.482664.a) 
15  German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Division of Stem Cells and Cancer, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany (GRID:grid.482664.a); German Cancer Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2480996076
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.